
A new drug approved months ago to help prevent Covid-19 infections could be a game changer for high-risk people — if they can get their hands on it. But many say they have struggled to access the medication.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance